Evidence map›Paper›PMID 41884975›Full record

ArticleFundamental & clinical pharmacology2026

Factors Associated With Cocaine Use Disorder: Results From the French Nationwide Repeated Cross-Sectional OPPIDUM Study (2019-2023).

Zenab Alhamidi, Clémence Lacroix, Elisabeth Jouve, Thomas Soeiro, Céline Eiden, Joëlle Micallef

Abstract read
In one paragraph

Article in Fundamental & clinical pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zenab AlhamidiCentre d'évaluation et d'information sur la pharmacodépendance - Addictovigilance Aix Marseille Univ, APHM, INSERM, Inst Neurosci Syst, UMR 1106, University Hospital, Service de Pharmacologie Clinique et Pharmacosurveillance, Marseille, France.
Clémence LacroixCentre d'évaluation et d'information sur la pharmacodépendance - Addictovigilance Aix Marseille Univ, APHM, INSERM, Inst Neurosci Syst, UMR 1106, University Hospital, Service de Pharmacologie Clinique et Pharmacosurveillance, Marseille, France.ORCID https://orcid.org/0000-0002-6857-4698
Elisabeth JouveCentre d'évaluation et d'information sur la pharmacodépendance - Addictovigilance Aix Marseille Univ, APHM, INSERM, Inst Neurosci Syst, UMR 1106, University Hospital, Service de Pharmacologie Clinique et Pharmacosurveillance, Marseille, France.ORCID https://orcid.org/0000-0002-4873-6522
Thomas SoeiroCentre d'évaluation et d'information sur la pharmacodépendance - Addictovigilance Aix Marseille Univ, APHM, INSERM, Inst Neurosci Syst, UMR 1106, University Hospital, Service de Pharmacologie Clinique et Pharmacosurveillance, Marseille, France.ORCID https://orcid.org/0000-0003-2604-9673
Céline EidenAddictovigilance Centre, Site Unique de Biologie, CHU Montpellier, Montpellier, France.ORCID https://orcid.org/0000-0002-7839-9811
Joëlle MicallefCentre d'évaluation et d'information sur la pharmacodépendance - Addictovigilance Aix Marseille Univ, APHM, INSERM, Inst Neurosci Syst, UMR 1106, University Hospital, Service de Pharmacologie Clinique et Pharmacosurveillance, Marseille, France.ORCID https://orcid.org/0000-0002-7172-7835

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cocaine use has increased both globally and nationally. This trend is accompanied by a rise in clinical complications. The objective of our study was to identify factors observed to be associated with cocaine use disorder, using data from the OPPIDUM program, collecting information directly from patients with substance use disorders recruiting in care or harm reduction facilities. Cocaine users were divided into two groups: cocaine use disorder and simple use. A univariate analysis was performed to compare the groups, followed by a multivariate analysis to identify factors associated with cocaine use disorder. Between 2019 and 2023, 6863 cocaine users (28% of all OPPIDUM participants) from 116 addiction treatment centers were included. Several factors were found to be significantly associated with cocaine use disorder: extreme precariousness (OR = 1.34, 95% CI [1.12-1.61], p = 0.002), cocaine-only use (OR = 1.90, 95% CI [1.45-2.50], p < 0.0001), alcohol dependence (OR = 1.48, 95% CI [1.30-1.68], p < 0.0001), and use of antidepressants and antipsychotics (OR = 2.08, 95% CI [1.37-3.16], p = 0.001; OR = 1.94, 95% CI [1.40-2.69], p < 0.001). These findings highlight several key factors associated with cocaine use disorder and their clinical implications. The study has limitations: potential selection bias, repeated inclusion of the same users across years, multiple modes of cocaine use, and the exploratory nature of the analyses due to uncontrolled alpha risk. Nevertheless, these insights can help healthcare professionals better understand patient profiles and provide more tailored care and prevention strategies.

Indexed as

Cocaine-Related DisordersAdultAlcoholismAntidepressive AgentsAntipsychotic AgentsCross-Sectional StudiesFemaleFranceHumansMaleMiddle AgedRisk FactorsSubstance Abuse Treatment CentersAntidepressive AgentsAntipsychotic Agentsabuseaddictovigilancecocainedependence

Identifiers

PMID41884975
PMCPMC13019272

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.